CRBU as of Oct 31 · 15:28 ET
CRBUNasdaqBiological Products, (No Diagnostic Substances)

Caribou Biosciences, Inc. · Brief

Next report

11 days

Nov 11 · after closeest.Q3 FY26

Expected move

No implied move.

Implied vs realized

1 reportHistory
—≥ implied
Q2 FY26±44.6%▼−1.86%×0.04
quarterimplied−45%0+45%realized×
Q2 FY26±44.6%▼−1.86%×0.04
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 11 report · est.

Bull2

12disclosed supplier and customer ties in SEC filingsSEC filings
+61.75%change in shares held by the ten largest reporting managers over the latest quarter13F · Jun 30 '26

Bear2

19managers whose positions together make up four fifths of the reported value13F · Jun 30 '26
4 of 24of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

CRBU report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 6haltTrading halt: 16:01 ET, resumed 16:25 ET.Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.